Professor, Internal Medicine, U of UT Sch of Med
Oncology
Dr. John C. Ruckdeschel, MD
|
|
Give Review
John C. Ruckdeschel, MD practices Oncology. He went to Albany Medical College. He has 1 awards "Whos Who in Medicine and Healthcare". John C. Ruckdeschel, MD has written publications. He has 98 publications published with PubMed. The lastest publication is: 'Application of laser cytometry to the analysis of immunologically induced in vitro lymphocyte responsiveness.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Randomized phase II trial of pemetrexed/cisplatin with or without CBP501 in patients with advanced malignant Pleural mesothelioma.
- Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non-Small-Cell Lung Cancer:...
- Randomized clinical trial of a brief and extensive dyadic intervention for advanced Cancer patients and their family caregivers.
- Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung Cancer.
- The outcome of medical intensive care for lung Cancer patients: the case for optimism.
- Community-level social support responses in a slow-motion technological disaster: the case of Libby, Montana.
- Phase II trial of imatinib maintenance therapy after irinotecan and cisplatin in patients with c-Kit-positive, extensive-stage small-cell lung Cancer.
- Pulmonary metastasis of basal cell carcinoma: a rare manifestation of a common disease with variable clinical course.
- Chronic obstructive lung diseases and risk of non-small cell lung Cancer in women.
- Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung Cancer.
- Influence of clinical communication on patients' decision making on participation in clinical trials.
- Parents' Empathic Responses and Pain and Distress in Pediatric Patients.
- The roles of patients' internet use for Cancer information and socioeconomic status in oncologist-patient communication.
- Phase II study of gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), and celecoxib, a cyclooxygenase-2 (COX-2) inhibitor, in patients...
- Second-line chemotherapy for non-small cell lung Cancer.
- Discussing bad news in the outpatient oncology clinic: rethinking current communication guidelines.
- Familial lung Cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease.
- Communication and informed consent.
- Risk of lung Cancer among white and black relatives of individuals with early-onset lung Cancer.
- Genetic linkage of prostate Cancer risk to the chromosome 3 region bearing FHIT.
- A portable, unobtrusive device for videorecording clinical interactions.
- Fatigue is becoming an exhausting problem.
- Early detection and treatment of spinal cord compression.
- The problem of Cancer: lung Cancer as a paradigm--keynote address summary.
- Real-time patient satisfaction survey and improvement process.
- Gefitinib (ZD1839) in previously treated advanced non-small-cell lung Cancer: experience from a single institution.
- Understanding patient decisions about clinical trials and the associated communication process: a preliminary report.
- Efficacy and costs of two forms of stress management training for Cancer patients undergoing chemotherapy.
- Quality-of-life-adjusted survival analysis of high-dose adjuvant interferon alpha-2b for high-risk melanoma patients using intergroup clinical trial data.
- Environmental exposure to Libby Asbestos and mesotheliomas.
- Unconventional style reaps rewards for Ruckdeschel. Physician executive's career carries Cancer center to the forefront. Interview by Patty Ryan.
- A prospective randomized trial to determine the benefit of surgical resection of residual disease following response of small cell lung Cancer to combination chemother...
- Effects of sex, thyro-parathyroidectomy, and light regime on levels and circadian rhythms of wheel-running in rats.
- Chemotherapy for esophageal Cancer with mitoguazone, methotrexate, bleomycin, and cisplatin.
- Dose and treatment factors in radiation-related pericardial effusion associated with the mantle technique for Hodgkin''s disease.
- Prospective trial evaluating immunocytochemical-based sputum techniques for early lung Cancer detection: assays for promotion factors in the bronchial lavage.
- Multicenter phase II study of brequinar sodium in patients with advanced lung Cancer.
- Therapeutic options for the treatment of small cell and non-small cell lung Cancer.
- Cellular characterization of lung Cancer. A caveat.
- Psychosocial oncology research. Where we have been, where we are going, and why we will not get there.
- Preoperative chemotherapy for locally advanced non-small cell lung Cancer.
- Lung tumor resection does not affect debrisoquine metabolism.
- The future role of carboplatin.
- The early detection of second primary lung Cancers by sputum immunostaining. LCEWDG Investigators. Lung Cancer Early Detection Group.
- Impact of neuroendocrine differentiation in non-small cell lung Cancer. The LCSG experience.
- Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically u...
- Quality of life in lung Cancer surgical adjuvant trials.
- Application of laser cytometry to the analysis of immunologically induced in vitro lymphocyte responsiveness.
- Quantitative and qualitative analysis of human lymphocyte proliferation to specific antigen in vitro by use of the helium neon laser.
- Amantadine and pulmonary peripheral airways.
- Cell-associated immunity to measles (rubeola). The demonstration of in vitro lymphocyte tritiated thymidine incorporation in response to measels complement fixation an...
- Sequential radiotherapy and adriamycin in the management of bronchogenic carcinoma: the question of additive toxicity.
- Serial quantitation of in vitro lymphocyte responsiveness to concanavalin A.
- Small cell anaplastic carcinoma of the Lung: changing concepts and emerging problems.
- Herpes zoster and impaired cell-associated immunity to the varicella-zoster virus in patients with Hodgkin''s disease.
- Methotrexate, bleomycin, and high-dose-cis-dichlorodiammineplatinum(II) in the treatment of advanced epidermoid carcinoma of the head and neck.
- Single-agent therapy for renal cell carcinoma: CCNU, vinblastine, thioTEPA, or bleomycin.
- The demonstration of cell-associated immunity to viruses. In vitro lymphocyte responsiveness to Varicella-zoster antigen.
- Combination chemotherapy versus single agents followed by combination chemotherapy in stage IV non-small-cell lung Cancer: a study of the Eastern Cooperative Oncology ...
- Phase II study of N-methylformamide, spirogermanium, and 4-demethoxydaunorubicin in the treatment of non-small cell lung Cancer (EST 3583): an Eastern Cooperative Onco...
- Attempts to enhance locoregional control of Cancer by radiotherapy, phototherapy, and combined modality therapy.
- Lung Cancer in patients seropositive for human immunodeficiency virus.
- Physician behaviors, patient perceptions, and patient characteristics as predictors of satisfaction of hospitalized adult Cancer patients.
- Primary central nervous system lymphoma in patients with and without the acquired immune deficiency syndrome. A retrospective analysis and review of the literature.
- Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung Cancer.
- Is chemotherapy for metastatic non-small cell lung Cancer "worth it"?
- The clinical significance of variant-morphology small-cell carcinoma of the Lung.
- A randomized comparison of standard chemotherapy versus alternating chemotherapy and maintenance versus no maintenance therapy for extensive-stage small-cell Lung canc...
- Metastatic breast Cancer in a young patient seropositive for human immunodeficiency virus.
- Social environment and social support.
- Etoposide in the management of non-small cell lung Cancer.
- A randomized trial to compare intravenous and oral etoposide in combination with cisplatin for the treatment of small cell lung Cancer.
- The impact of family presence on the physician-Cancer patient interaction.
- IntraPleural therapy for malignant Pleural effusions. A randomized comparison of bleomycin and tetracycline.
- Special problems in the older Cancer patient: spinal cord compression and pleural effusions.
- N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung Cancer cell lines.
- Bleomycin and tetracycline in malignant Pleural effusions: a review.
- The role of standard-dose etoposide in the management of non-small cell lung Cancer.
- Chemotherapy of metastatic non-small cell carcinoma of the Lung.
- Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome.
- Suppression of in vitro lymphocyte responsiveness to purified protein derivative by measles virus. A reexploration of the phenomenon.
- Mycoplasma contamination of membrane associated measles antigens. Inability to demonstrate in vitro lymphocyte responsiveness to measles.
- Radiation-related pericardial effusions in patients with Hodgkin''s disease.
- A white blood cell RNase assay for the possible monitoring of malignancy.
- Additional evidence that the cell-associated immune system is the primary host defense against measles (rubeola).
- Radiation-related pericarditis.
- The cost of success in the treatment of thoracic malignancies.
- Concurrent paclitaxel/cisplatin with thoracic radiation in patients with stage IIIA/B non-small cell carcinoma of the Lung.
- Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung Cancer: an Eastern Cooperative Oncology Group pilot st...
- Future directions in non-small cell lung Cancer. A personal view.
- Controversy over sclerotherapy for malignant Pleural effusions.
- Continuous infusion bleomycin in AIDS-related Kaposi's sarcoma.
- Attitudes toward Cancer: I. The impact of a comprehensive oncology course on second-year medical students.
- Noninvasive evaluation of mediastinal metastases in bronchogenic carcinoma: a prospective comparison of chest radiography and gallium-67 scanning.
- Attitudes toward Cancer. II: A comparative analysis of Cancer patients, medical students, medical residents, physicians and Cancer educators.
- Content bias in the neoplastic-related items of the National Board of Medical Examiners Part II Examination.
- Chemotherapy for inoperable, non-small cell bronchogenic carcinoma: EST 2575, generation II.
Schools
Albany Medical College
Johns Hopkins Hospital
Beth Israel Hospital
Conditions Treated
- Adrenal Gland Cancer
- Lung Cancer
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Whos Who in Medicine and Healthcare
Education
-
Beth Israel Deaconess Medical Center -
Johns Hopkins University -
Albany Medical College
Drug Facts
| NPI NUMBER | 1356380851 | |
| NPPES Provider LastName | RUCKDESCHEL | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 891280443 | |
| NPPES Provider State | NV | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 103.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356380851 |
| Last Name Of The Provider | RUCKDESCHEL |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
Dr. Brian D. Vicuna, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sreekanth Donepudi, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Lin-Chi Chen, MD |
|
Dr. Hamidreza Sanatinia, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ghulam H. Kashef, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shamoon Ahmad, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Oscar B. Goodman Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph Quagliana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. M Nafees Nagy, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Raja S. Mehdi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew D. Galsky, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahid P. Malik, MD
This Doctor is OpenDoctor Recommended.
|